Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC1 | Q13547 | 13/20 | 0.36 |
| ▸ | HDAC2 | Q92769 | 13/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | EHMT2 | Q96KQ7 | 1/20 | 0.30 |
| ▸ | EHMT1 | Q9H9B1 | 1/20 | 0.30 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL574826 | 0.86 | HDAC1 (0.37) | HDAC1HDAC2ALDH1A1LMNAMAPT | |
| SCHEMBL551390 | 0.80 | ALDH1A1 (0.44) | HDAC1HDAC2ALDH1A1LMNAMAPT | |
| SCHEMBL17283454 | 0.79 | HDAC1 (0.43) | HDAC1HDAC2ALDH1A1LMNASMN1; SMN2 | |
| SCHEMBL29459657 | 0.77 | ALDH1A1 (0.43) | HDAC1HDAC2ALDH1A1MAPTKMT2A | |
| SCHEMBL1120092 | 0.77 | ALDH1A1 (0.43) | HDAC1HDAC2ALDH1A1MAPTKMT2A | |
| SCHEMBL18052248 | 0.76 | EHMT2 (0.38) | HDAC1HDAC2ALDH1A1MAPTKMT2A | |
| SCHEMBL17758942 | 0.76 | ALDH1A1 (0.39) | HDAC1HDAC2ALDH1A1LMNAMAPT | |
| SCHEMBL11927655 | 0.76 | EHMT2 (0.40) | HDAC1HDAC2ALDH1A1LMNAMAPT | |
| SCHEMBL18726574 | 0.73 | HDAC1 (0.37) | HDAC1HDAC2ALDH1A1LMNAMAPT | |
| SCHEMBL574827 | 0.73 | HDAC1 (0.37) | HDAC1HDAC2ALDH1A1LMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4378958-A2 | HIGH-AFFINITY ANTI-MERTK ANTIBODIES AND USES THEREOF | Inspirna, Inc. (US) | 2024-06-05 | — | — | EP | disclosed |
| EP-3930847-B1 | HIGH-AFFINITY ANTI-MERTK ANTIBODIES AND USES THEREOF | INSPIRNA INC (US) | 2024-02-14 | — | — | EP | disclosed |
| US-20230146646-A1 | ANTI-MERTK AGONISTIC ANTIBODIES AND USES THEREOF | THE ROCKEFELLER UNIVERSITY (US) | 2023-05-11 | — | — | US | disclosed |
| US-11613588-B2 | Anti-mertk agonistic antibodies and uses thereof | THE ROCKEFELLER UNIVERSITY (US) | 2023-03-28 | — | — | US | disclosed |
| US-20220220222-A1 | HIGH-AFFINITY ANTI-MERTK ANTIBODIES AND USES THEREOF | INSPIRNA, INC. (US) | 2022-07-14 | — | — | US | disclosed |
| US-11242407-B2 | High-affinity anti-MERTK antibodies and uses thereof | INSPIRNA, INC. (US) | 2022-02-08 | — | — | US | disclosed |
| EP-3930847-A1 | HIGH-AFFINITY ANTI-MERTK ANTIBODIES AND USES THEREOF | Inspirna, Inc. (US) | 2022-01-05 | — | — | EP | disclosed |
| US-20200291135-A1 | HIGH-AFFINITY ANTI-MERTK ANTIBODIES AND USES THEREOF | RGENIX, INC. (US) | 2020-09-17 | — | — | US | disclosed |
| US-20200255543-A1 | ANTI-MERTK AGONISTIC ANTIBODIES AND USES THEREOF | THE ROCKEFELLER UNIVERSITY (US) | 2020-08-13 | — | — | US | disclosed |
| EP-3645041-A1 | ANTI-MERTK AGONISTIC ANTIBODY-DRUG CONJUGATES AND USES THEREOF | The Rockefeller University (US) | 2020-05-06 | — | — | EP | disclosed |
| WO-2019005756-A1 | ANTI-MERTK AGONISTIC ANTIBODY-DRUG CONJUGATES AND USES THEREOF | THE ROCKEFELLER UNIVERSITY (US) | 2019-01-03 | — | — | WO | disclosed |